Singapore hospital tests 'Living Drug' to fight aggressive lymphoma
NCT ID NCT07319676
Summary
This trial is testing a personalized cell therapy for patients whose B-cell lymphoma has returned or not responded to other treatments. Doctors will modify a patient's own immune cells to better target and fight their cancer. The study will first find a safe dose and then see how well the therapy works in about 30 patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B-CELL LYMPHOMA REFRACTORY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.